Table 1.
Comparisons summary of 2D culture and 3D culture.
| Models | ||||
|---|---|---|---|---|
| 2D Culture | 3D Culture | References | ||
Cell Culture
|
Spheroids
|
Organoids
|
||
| Accessibility | More easily accessible as well-established culture reagents and cell lines easily available. | Accessible due to cellular sources and reagent availability. | More novel than the previous two methods, accessibility remains limited due to specific reagent suppliers and tissue availability from patients. | (59) |
| Cost to maintain cultures | Relatively cheap to maintain as commercially available reagents and assays. | Lower cost in comparison to organoids, but requires time to initiate and develop cultures. | More expensive, fewer commercially available tests and reagents. Can also be quite costly to initiate and develop cultures. | (58, 60) |
| Well-established culture protocols | Well-established and standardized protocols available for a variety of cell lines. | There are a number of well-established protocols (suspension culture, scaffold culture, etc) but use may be dependent on the type of experiments | Some well-established protocols available but no standardized protocols. | (56, 59, 61) |
| Time expenditure to establish culture | Within a few hours to a few days | Within a few days to a few weeks | Within a few weeks to a few months | (62–64) |
| Patient-specific & cellular sources | Yes, can derived from an established single cell-line or from patient primary cells | Yes, can be derived from patient primary cells or established cell-lines can be used | Yes, patient samples can be digested and specific cell-types harvested to generate organoids | (16) |
| Cellular characteristics | Cells often present with a flat and elongated shape. Cells are grown as monolayers and can only expand in two-dimensions | Cells are able to maintain their natural 3D shape and are able to form multiple layers and grow in three-dimensions as it would occur in-vivo | (60, 65–68) | |
| Cell proliferation rates | Cell proliferation occurs at an unnatural rate and often cells are at the same stage of growth | Cell proliferation occurs at more natural rates and cells are sometimes at different stages of growth (as seen in-vivo) | (67, 69) | |
| Gene and protein expression levels | Expression levels are vastly different when compared to in-vivo systems | Expression levels have been found to resemble those seen in-vivo | (60, 66, 67, 69) | |
| Sensitivity to drugs | Cells present with minimal resistance to drugs, which can result in successful outcomes to administered drugs | Often present with more resistance to administered drug treatments, showing a more holistic overview to drug metabolism in-vivo. | (67, 70, 71) | |
| Tumor microenvironment | Single cell types are often cultured without additional cell types, there is limited tumor heterogeneity, there is often no ECM substance and cell-cell interactions is limited to between one cell type. Therefore, does not accurately represent the tumor microenvironment. | Multiple cell types can be cultured together, there is better tumor heterogeneity observed, ECM substrate is present and cell-cell interactions can be observed between different cell types. Therefore, the tumor microenvironment is more accurately represented. | (72, 73) | |
| Usage, analysis & reproducibility | Easily used to generate results and analysis is easily interpretable. Results are also easily reproducible | Usage can vary from user-to-user and from experiments, analysis can also be difficult to perform due to 3D nature and reproducibility remains an issue | (56, 74, 75) | |